A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Clinical trial NCT02381886 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02381886
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-06
- Primary completion
- 2016-12-07
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.